Related Experiment Video
Updated: Jan 6, 2026

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
Targeting Strategies of Stem Cell-Derived Extracellular Vesicles in the Treatment of Cardiovascular Diseases
Jiaming Fan1, Liyun Yao1, Jiayi Yao1
1Department of Cardiovascular Surgery of the First Affiliated Hospital& Institute for Cardiovascular Science, Soochow University, No. 899, Pinghai Road, Suzhou, 215006, China.
Insights
Extracellular vesicles (EVs) show promise for cardiovascular disease (CVD) treatment. Strategies are emerging to improve EV retention and heart-specific delivery, overcoming limitations of current therapies.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cardiology
Background:
- Cardiovascular disease (CVD) remains a leading cause of global mortality, with limited regenerative capacity of heart tissue.
- Current treatments like drugs, surgery, and heart transplantation have significant limitations, including donor scarcity and risks.
- Stem cell therapy offers potential but suffers from poor cell retention, while extracellular vesicles (EVs) derived from stem cells face challenges like short half-life and non-specific uptake.
Purpose of the Study:
- To review the current understanding of extracellular vesicles (EVs) for cardiovascular disease (CVD) treatment.
- To examine advanced strategies aimed at enhancing EV retention and targeted delivery to the heart.
- To discuss the therapeutic potential and future directions of EV-based therapies for CVD.
Main Methods:
- Review of current literature on extracellular vesicle (EV) biology and application in cardiovascular disease.
- Analysis of strategies to improve EV therapeutic efficacy, including hydrogel incorporation, membrane modification, fusion techniques, and immune system modulation.
- Discussion of methods to overcome challenges such as short plasma half-life and non-specific organ uptake.
Main Results:
- Extracellular vesicles (EVs) are key mediators of stem cell paracrine effects and hold therapeutic potential for cardiovascular diseases.
- Various strategies are being developed to enhance EV stability, prolong circulation time, and improve targeting to cardiac tissue.
- Techniques like hydrogel encapsulation and modification of EV surface properties show promise in reducing clearance by the reticuloendothelial system.
Conclusions:
- Extracellular vesicle (EV) therapy presents a promising avenue for treating cardiovascular diseases by potentially regenerating heart tissue.
- Overcoming challenges related to EV stability, biodistribution, and targeted delivery is crucial for clinical translation.
- Continued research into EV engineering and delivery systems will be vital for realizing their full therapeutic potential in cardiology.
Abstract:
Cardiovascular disease (CVD) is a significant cause of cardiac and vascular-related deaths worldwide. While traditional drug and surgical treatments can alleviate symptoms and slow progression, they cannot regenerate heart tissue or reverse function. Heart transplantation, although a radical cure, is limited by donor availability, risks, and costs. Stem cell therapy has gained attention as a potential treatment option, but is hindered by low retention rates post-transplantation. Extracellular vesicles (EVs) are nanoscale membrane vesicles found in various cells and play a key role in the paracrine effects of stem cells. Despite being a promising treatment for cardiovascular diseases, the short plasma half-life and non-specific uptake by the liver and spleen significantly impact its therapeutic efficacy in the heart. This review examines the current understanding of extracellular vesicles and recent advancements in strategies to reduce EV loss and enhance targeted delivery for cardiovascular disease treatment. Approaches such as hydrogel incorporation, vesicular membrane modifications, fusion techniques, and inhibition of monocyte-macrophage system (MPS) clearance are discussed. The paper concludes by addressing the current status of extracellular vesicle therapy and provides insights into its future development.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Mesenchymal Stem Cells
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stem Cell Culture

